{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:37:36Z","timestamp":1761748656225,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":660,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.acvd.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T21:04:58Z","timestamp":1320095098000},"page":"565-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cystatin C levels are associated with the prognosis of systolic heart failure patients"],"prefix":"10.1016","volume":"104","author":[{"given":"Changlu","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2011.08.003_bib0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1051\/medsci\/2004206-7651","article-title":"Cell transplantation in heart failure management","volume":"20","author":"Vilquin","year":"2004","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.acvd.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","article-title":"Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure","volume":"97","author":"Mallat","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","article-title":"Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction","volume":"96","author":"Hill","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000055318.09997.1F","article-title":"Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes","volume":"107","author":"Suematsu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0025","doi-asserted-by":"crossref","first-page":"H840","DOI":"10.1152\/ajpheart.00519.2008","article-title":"NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart","volume":"296","author":"Zhang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0735-1097(02)01721-7","article-title":"Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure","volume":"39","author":"Tsutsui","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0035","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2004.01.036","article-title":"Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction","volume":"43","author":"Valgimigli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0040","first-page":"55","article-title":"Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction","volume":"18","author":"Agoston-Coldea","year":"2011","journal-title":"Cardiol J"},{"key":"10.1016\/j.acvd.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/01.CIR.0000016721.84535.00","article-title":"Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat","volume":"105","author":"Sia","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0050","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/01.CIR.0000018605.14470.DD","article-title":"Carvedilol decreases elevated oxidative stress in human failing myocardium","volume":"105","author":"Nakamura","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0055","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/hc4901.101347","article-title":"8-oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts","volume":"104","author":"Tsutsui","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0060","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0735-1097(01)01596-0","article-title":"Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy","volume":"38","author":"Shite","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.99.20.2645","article-title":"Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure","volume":"99","author":"Kukin","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCOUTCOMES.110.957696","article-title":"Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis","volume":"3","author":"Lee","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.acvd.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ajh.2010.215","article-title":"Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus","volume":"24","author":"Sahakyan","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.acvd.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2459\/JCM.0b013e328349187c","article-title":"The status of coronary artery lesions in patients with conduction disturbance","volume":"12","author":"Wei","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.acvd.2011.08.003_bib0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3904\/kjim.2010.25.3.253","article-title":"Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure","volume":"25","author":"Park","year":"2010","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.acvd.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjcard.2007.08.038","article-title":"Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure","volume":"101","author":"Tang","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2008.11.131","article-title":"Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome","volume":"141","author":"Maurer","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cardfail.2008.01.006","article-title":"Impact of myocardial function on cystatin C measurements in chronic systolic heart failure","volume":"14","author":"Tang","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.acvd.2011.08.003_bib0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11897-011-0065-5","article-title":"Novel biomarkers in acute heart failure","volume":"8","author":"Yanavitski","year":"2011","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.acvd.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.0000015507.29953.38","article-title":"Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies","volume":"105","author":"Burke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.47102\/annals-acadmedsg.V33N4p407","article-title":"High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction","volume":"33","author":"Low","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.acvd.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/JDI-100104727","article-title":"Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates","volume":"23","author":"Risch","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.acvd.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2005.06.017","article-title":"Plasma cystatin-C and development of coronary heart disease: the PRIME Study","volume":"185","author":"Luc","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2011.08.003_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/HCO.0b013e328338bc2d","article-title":"Lipid-lowering drugs and heart failure: where do we go after the statin trials?","volume":"25","author":"Strandberg","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jjcc.2010.02.003","article-title":"Effects of statin and lipoprotein metabolism in heart failure","volume":"55","author":"Miura","year":"2010","journal-title":"J Cardiol"},{"key":"10.1016\/j.acvd.2011.08.003_bib0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/eurjhf\/hfp129","article-title":"Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)","volume":"11","author":"Holme","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611002762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611002762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:39:20Z","timestamp":1761745160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213611002762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1875213611002762"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2011.08.003","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystatin C levels are associated with the prognosis of systolic heart failure patients","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2011.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}